NFL reviews Eagles handling of Jalen Hurts blood clot treatment

National Football League leadership and the NFL Players Association are reviewing how the Philadelphia Eagles handled the medical care of quarterback Jalen Hurts, according to reports from the Daily Mail and the New York Post. The decision by the Eagles medical staff to allow Hurts to play despite a blood clot has drawn scrutiny across the league. Both the league and the players association announced they are working together to review the situation. [2][3][4]

The NFL is annoyed with the Eagles for a lack of transparency in public statements regarding the treatment of Hurts for blood clots in his leg and lungs, according to the New York Post. The Philadelphia Inquirer reported that officials were furious over the team's public communication, although the league reportedly had no issues with the initial timeline and medical treatment. [3][4]

Sports agent Leigh Steinberg told Fox News that the case will put the league on alert. Steinberg stated that he would have contacted team doctors to seek answers if he represented a quarterback facing a similar medical situation. He added that medical experts must ultimately determine whether the Eagles handled the quarterback's care appropriately. [1]

Hurts, who began his college football career at Alabama before playing at Oklahoma, is the professional quarterback for the Philadelphia Eagles. As FTMQ News reported earlier, Hurts was ruled out for the remainder of the 2026 NFL season to undergo medical treatment after blood clots were discovered in his lungs following a calf injury. [5][9][10]